Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
Metabolic dysfunction-Associated Steatotic Liver Disease
Fatty Liver Disease (NAFLD and NASH)
![](http://img1.wsimg.com/isteam/ip/0e230687-1eeb-45c5-bcb6-fc3853fdb103/Community%20-%20Homepage%20shot.jpg/:/)
Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
Fatty Liver Disease (NAFLD and NASH)
Millions are affected by fatty liver disease, and raising awareness is crucial. Wendy Schaufert has dedicated 10 years to working with patients, focusing on metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), formerly NAFLD/NASH.
Dr. Mark Swain, Hepatologist answers an audience question at our Calgary event and shares one real world patient story about Ozempic and the impact it had on their life and daily routine.
Dr. Swain provides an in-depth explanation of Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic dysfunction-Associated Steatohepatitis (MASH), highlighting the importance of recognizing and addressing these conditions early.
Video #2: Check out the interest from the Calgary, AB community.
Liam Swain sharing the Madrigal Pharmaceuticals liver model on Global Fatty Liver Day.
We had an incredible event on June 13, 2024, for Global Fatty Liver Day! It was a privilege to host such a knowledgeable and engaged community in Calgary. As the President and Founder of the Fatty Liver Alliance, I’m thrilled to share some highlights and key takeaways from our first presentation titled "Your Liver, Your Health: Understanding Metabolic Dysfunction."
How often does a study get you AMPED? Jonathan G. Stine, MD MSc, FACP leads by example and shares his latest study on the impact of different doses of aerobic exercise training for MASLD patients, with Michael Betel.
Fatty liver disease, encompassing both Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic dysfunction-Associated Steatohepatitis (MASH), is a growing concern globally. By the time symptoms appear, significant liver damage might have already occurred. Early assessment can prevent progression, manage comorbidities and ensure that patients receive tailored treatment.
Dr. Jason Fung explains that intermittent fasting is an effective strategy for managing and reversing fatty liver disease, including Metabolic Associated Steatotic Liver Disease (MASLD) and Metabolic Associated Steatohepatitis (MASH).
Just posted here is the complete set of videos from our Primary Care Summit. With 4.5 hours of presentations approved for CME credits in its live version, feel confident that the information shared is accurate and reputable.
Presentations were done by internationally recognized and respected liver and metabolic health experts.
Walking 150 minutes a week is the amount of moderate-intensity aerobic activity recommended by leading health organizations like the World Health Organization, the CDC, the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and many others.
Today's blog explores 10 reasons why it's worth walking 150 minutes per week:
Fatty liver disease is a growing health problem that often doesn’t show symptoms until it's serious. Dr. Swaranjit Bhasin, an experienced radiologist, offers three practical steps to help not just control, but possibly even reverse this condition by making some key changes to your daily habits.
In episode 10/10 of our "Liver Insights" series, we have a fabulous discussion with Jeff Lazarus, Professor of Global Health, CUNY Graduate School of Public Health and Health Policy and Research Professor at Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Today's discussion is: "Community and Support Systems: Building and leveraging support networks for enhanced coping and management."
For those living with MASLD or MASH, this discussion can be empowering. Recognizing the value of a diagnosis, utilizing support networks, and embracing lifestyle modifications with the support of loved ones can significantly impact one's quality of life and the progression of the disease.
Our amazing team of full and part-time volunteers are committed to helping others. We take our convictions and turn them into action. Think you would be a good fit? Get in touch for more information!
Our nonprofit charity was created to build a supportive community. Canada’s population is about 38.8M with an estimated 11.64M who may have Metabolic Dysfunction Associated Liver Disease (MASLD) (formerly NAFLD). Of those, an estimated 20% - 25% will progress to cirrhosis and suffer with Metabolic-dysfunction Associated Steatohepatitis (MASH) (formerly NASH).
We raise awareness about the risks, causes and complications of fatty liver disease and help those already diagnosed with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) by advocating for access to approved treatments and care.
Your support and contributions will enable our Registered Charity to meet our goals and your generous donations will fund our mission and purpose. Charity #79690 4704 RR0001
We will issue a tax receipt for donations of $18.00 or greater.
**Best option for us, is e-transfer to donations@fattyliver.ca
In the comment section, we need your full name and address so we can issue a tax receipt. Other payment options below.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.